Dr Julio Cesar Aguilar Rubido is a scientific researcher with more than 27 years of experience in the field of vaccines and specialized in adjuvant strategies, the immunology of vaccines, and biotechnological product development from patent to registration. In addition, he specializes in the writing, planning, development, monitoring, and auditing of clinical trials from phase I to III, the writing of clinical trials' final reports, and scientific discussions with regulatory authorities, IRBs, auditors, and patent officers. His scientific activities as a professional researcher started as a Havana University graduate student in the specialty of biochemistry, Faculty of Biology. He has been a Senior Researcher of the Hepatitis B and Adjuvant Development Section at the Vaccine Department of the Center for Genetic Engineering and Biotechnology (CIGB, Havana) for the last 20 years.